AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2023
May 24, 2023
32227_dirs_2023-05-24_1bc75372-e34c-4ce5-a655-73a4a97f1426.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-05-15
Reporting Person: Aunan Greg D (Chief Accounting Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 15390 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.62 | 2030-05-01 | Common Stock (28662.0) | Direct |
Footnotes
F1: On May 1, 2023, Mr. Aunan was granted 28,662 stock options. These options vest ratably over the first four anniversary dates of the grant date.
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24